Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cruciani

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 10, 1995
A novel strategy for improving ligand selectivity in receptor-based drug designM Pastor, G Cruciani
The Analyst|April 4, 2000
Experimental design and multivariate calibration in the development, set-up and validation of a differential pulse polarographic and UV spectrophotometric method for the simultaneous plasmatic determination of the therapeutic metronidazole-pefloxacin combinationP Gratteri, G Cruciani
Journal of Molecular Graphics|June 1, 1994
A search for specificity in DNA-drug interactionsG Cruciani, P J Goodford
Journal of Medicinal Chemistry|August 5, 1994
Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase bG Cruciani, K A Watson
Journal of Medicinal Chemistry|May 9, 1997
Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationshipsM Pastor, G Cruciani, S Clementi
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 18, 2000
VolSurf: a new tool for the pharmacokinetic optimization of lead compoundsG Cruciani, M Pastor, W Guba
Journal of Medicinal Chemistry|December 24, 1997
A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysisM Pastor, G Cruciani, K A Watson
Pharmaceutical Research|July 24, 2001
Synthesis, in vitro skin permeation studies, and PLS-analysis of new naproxen derivativesH Weber, U Steimer, R Mannhold, et al.
Journal of Computer-Aided Molecular Design|January 8, 1999
Multivariate analysis of experimental and computational descriptors of molecular lipophilicityR Mannhold, G Cruciani, K Dross, et al.
Journal of Medicinal Chemistry|July 6, 2000
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptorsM Fichera, G Cruciani, A Bianchi, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 10, 1995
A novel strategy for improving ligand selectivity in receptor-based drug designM Pastor, G Cruciani
The Analyst|April 4, 2000
Experimental design and multivariate calibration in the development, set-up and validation of a differential pulse polarographic and UV spectrophotometric method for the simultaneous plasmatic determination of the therapeutic metronidazole-pefloxacin combinationP Gratteri, G Cruciani
Journal of Molecular Graphics|June 1, 1994
A search for specificity in DNA-drug interactionsG Cruciani, P J Goodford
Journal of Medicinal Chemistry|August 5, 1994
Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase bG Cruciani, K A Watson
Journal of Medicinal Chemistry|May 9, 1997
Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationshipsM Pastor, G Cruciani, S Clementi
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 18, 2000
VolSurf: a new tool for the pharmacokinetic optimization of lead compoundsG Cruciani, M Pastor, W Guba
Journal of Medicinal Chemistry|December 24, 1997
A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysisM Pastor, G Cruciani, K A Watson
Pharmaceutical Research|July 24, 2001
Synthesis, in vitro skin permeation studies, and PLS-analysis of new naproxen derivativesH Weber, U Steimer, R Mannhold, et al.
Journal of Computer-Aided Molecular Design|January 8, 1999
Multivariate analysis of experimental and computational descriptors of molecular lipophilicityR Mannhold, G Cruciani, K Dross, et al.
Journal of Medicinal Chemistry|July 6, 2000
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptorsM Fichera, G Cruciani, A Bianchi, et al.
Pageof 8